Topics

Testing For COVID-19 In All Patients With Unexplained Pneumonia Is Probably Not Cost-Effective

09:50 EST 12 Feb 2020 | Forbes

At this point, is more widespread testing of all patients with unexplained pneumonia (even those who haven’t been to China) warranted from a societal cost-effectiveness perspective? It’s a question that needs to be asked.

Original Article: Testing For COVID-19 In All Patients With Unexplained Pneumonia Is Probably Not Cost-Effective

NEXT ARTICLE

More From BioPortfolio on "Testing For COVID-19 In All Patients With Unexplained Pneumonia Is Probably Not Cost-Effective"

Quick Search

Relevant Topic

Pulmonary
Pulmonary relating to or associated with the lungs eg Asthma, chronic bronchitis, emphysema, COPD, Cystic Fibrosis, Influenza,  Lung Cancer, Pneumonia, Pulmonary Arterial Hypertension, Sleep Disorders etc Follow and track Lung Cancer News ...